CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis

Afonina, 2015, MALT1—a universal soldier: multiple strategies to ensure NF-kappaB activation and target gene expression, FEBS J, 282, 3286, 10.1111/febs.13325 Afonina, 2016, The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes, EMBO Rep, 17, 914, 10.15252/embr.201642109 Ammar, 2013, Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families, Br J Dermatol, 168, 583, 10.1111/bjd.12050 Ammar, 2016, CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts, Br J Dermatol, 174, 330, 10.1111/bjd.14158 Bertin, 2001, CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B, J Biol Chem, 276, 11877, 10.1074/jbc.M010512200 Bornancin, 2015, Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation, J Immunol, 194, 3723, 10.4049/jimmunol.1402254 Cabalzar, 2013, Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface, PLoS One, 8, e72051, 10.1371/journal.pone.0072051 Coornaert, 2008, T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20, Nat Immunol, 9, 263, 10.1038/ni1561 Coto-Segura, 2016, Common and rare CARD14 gene variants affect the anti-TNF response among Psoriasis patients, Br J Dermatol, 175, 134, 10.1111/bjd.14461 Deng, 2000, Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain, Cell, 103, 351, 10.1016/S0092-8674(00)00126-4 Deng, 2016, The inflammatory response in psoriasis: a comprehensive review, Clin Rev Allergy Immunol, 50, 377, 10.1007/s12016-016-8535-x Eskin-Schwartz, 2016, Intra-familial variation in clinical phenotype of CARD14-related psoriasis, Acta Derm Venereol, 96, 885, 10.2340/00015555-2405 Eytan, 2014, Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14, Br J Dermatol, 171, 420, 10.1111/bjd.12952 Feng, 2016, CARD14 gene polymorphism c.C2458T (p.Arg820Trp) is associated with clinical features of psoriasis vulgaris in a Chinese cohort, J Dermatol, 43, 294, 10.1111/1346-8138.13065 Fontan, 2012, MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo, Cancer Cell, 22, 812, 10.1016/j.ccr.2012.11.003 Fuchs-Telem, 2012, Familial pityriasis rubra pilaris is caused by mutations in CARD14, Am J Hum Genet, 91, 163, 10.1016/j.ajhg.2012.05.010 Gaide, 2001, Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation, FEBS Lett, 496, 121, 10.1016/S0014-5793(01)02414-0 Gewies, 2014, Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation, Cell Rep, 9, 1292, 10.1016/j.celrep.2014.10.044 Gonzalez-Lara, 2013, SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort, DNA Cell Biol, 32, 601, 10.1089/dna.2013.2109 Gross, 2006, Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity, Nature, 442, 651, 10.1038/nature04926 Hailfinger, 2014, Targeting B-cell lymphomas with inhibitors of the MALT1 paracaspase, Curr Opin Chem Biol, 23, 47, 10.1016/j.cbpa.2014.09.025 Harden, 2015, The immunogenetics of psoriasis: a comprehensive review, J Autoimmun, 64, 66, 10.1016/j.jaut.2015.07.008 Harden, 2014, CARD14 expression in dermal endothelial cells in psoriasis, PLoS One, 9, e111255, 10.1371/journal.pone.0111255 Has, 2016, Target-sequence capture and high throughput sequencing identify a de novo CARD14 mutation in an infant with erythrodermic pityriasis rubra pilaris, Acta Derm Venereol, 96, 989, 10.2340/00015555-2446 Howes, 2016, Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-kappaB activation, Biochem J, 473, 1759, 10.1042/BCJ20160270 Hulpiau, 2016, MALT1 is not alone after all: identification of novel paracaspases, Cell Mol Life Sci, 73, 1103, 10.1007/s00018-015-2041-9 Inoue, 2016, CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis, J Dermatol, 43, 187, 10.1111/1346-8138.13008 Jaworski, 2014, Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity, EMBO J, 33, 2765, 10.15252/embj.201488987 Jordan, 2012, Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis, Am J Hum Genet, 90, 796, 10.1016/j.ajhg.2012.03.013 Jordan, 2012, PSORS2 is due to mutations in CARD14, Am J Hum Genet, 90, 784, 10.1016/j.ajhg.2012.03.012 Klein, 2015, The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-kappaB signalling, Nat Commun, 6, 8777, 10.1038/ncomms9777 Korber, 2013, Mutations in IL36RN in patients with generalized pustular psoriasis, J Invest Dermatol, 133, 2634, 10.1038/jid.2013.214 Li, 2015, Analysis of CARD14 polymorphisms in pityriasis rubra pilaris: activation of NF-kappaB, J Invest Dermatol, 135, 1905, 10.1038/jid.2015.65 Lim, 2015, Identification of beta-lapachone analogs as novel MALT1 inhibitors to treat an aggressive subtype of diffuse large B-cell lymphoma, J Med Chem, 58, 8491, 10.1021/acs.jmedchem.5b01415 Lowes, 2014, Immunology of psoriasis, Annu Rev Immunol, 32, 227, 10.1146/annurev-immunol-032713-120225 Lucas, 2001, Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway, J Biol Chem, 276, 19012, 10.1074/jbc.M009984200 Matsumoto, 2005, Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-kappaB activation, Immunity, 23, 575, 10.1016/j.immuni.2005.10.007 Mc Guire, 2014, Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis, J Neuroinflammation, 11, 124, 10.1186/1742-2094-11-124 McAllister-Lucas, 2001, Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction, J Biol Chem, 276, 30589, 10.1074/jbc.M103824200 Mease, 2013, Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics, J Am Acad Dermatol, 69, 729, 10.1016/j.jaad.2013.07.023 Mossner, 2015, Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-function mutations in IL36RN in European patients, J Invest Dermatol, 135, 2538, 10.1038/jid.2015.186 Nagel, 2012, Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL, Cancer cell, 22, 825, 10.1016/j.ccr.2012.11.002 Nestle, 2009, Psoriasis. N Engl J Med, 361, 496, 10.1056/NEJMra0804595 Nititham, 2015, Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseases, Genes Immun, 16, 120, 10.1038/gene.2014.75 Oeckinghaus, 2007, Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation, EMBO J, 26, 4634, 10.1038/sj.emboj.7601897 Oudot, 2009, An association study of 22 candidate genes in psoriasis families reveals shared genetic factors with other autoimmune and skin disorders, J Invest Dermatol, 129, 2637, 10.1038/jid.2009.157 Pelzer, 2013, The protease activity of the paracaspase MALT1 is controlled by monoubiquitination, Nat Immunol, 14, 337, 10.1038/ni.2540 Qiao, 2013, Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly, Mol Cell, 51, 766, 10.1016/j.molcel.2013.08.032 Qin, 2014, Variant analysis of CARD14 in a Chinese Han population with psoriasis vulgaris and generalized pustular psoriasis, J Invest Dermatol, 134, 2994, 10.1038/jid.2014.269 Rebeaud, 2008, The proteolytic activity of the paracaspase MALT1 is key in T cell activation, Nat Immunol, 9, 272, 10.1038/ni1568 Ruefli-Brasse, 2003, Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase, Science, 302, 1581, 10.1126/science.1090769 Ruland, 2003, Differential requirement for Malt1 in T and B cell antigen receptor signaling, Immunity, 19, 749, 10.1016/S1074-7613(03)00293-0 Schmitt, 2016, MALT1 Protease activity controls the expression of inflammatory genes in keratinocytes upon zymosan stimulation, J Invest Dermatol, 136, 788, 10.1016/j.jid.2015.12.027 Scudiero, 2014, The three CARMA sisters: so different, so similar: a portrait of the three CARMA proteins and their involvement in human disorders, J Cell Physiol, 229, 990, 10.1002/jcp.24543 Scudiero, 2011, Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-kappaB activation and endoplasmic reticulum stress-induced cell death, J Cell Physiol, 226, 3121, 10.1002/jcp.22667 Sommer, 2005, Phosphorylation of the CARMA1 linker controls NF-kappaB activation, Immunity, 23, 561, 10.1016/j.immuni.2005.09.014 Sugiura, 2015, Childhood-onset PsA in Down syndrome with psoriasis susceptibility variant CARD14 rs11652075, Rheumatology (Oxford), 54, 197, 10.1093/rheumatology/keu419 Sugiura, 2014, CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort, J Invest Dermatol, 134, 1755, 10.1038/jid.2014.46 Sun, 2004, The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes, Mol Cell, 14, 289, 10.1016/S1097-2765(04)00236-9 Tanner, 2007, CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation, J Biol Chem, 282, 17141, 10.1074/jbc.M700169200 te Velthuis, 2007, Molecular evolution of the MAGUK family in metazoan genomes, BMC Evol Biol, 7, 129, 10.1186/1471-2148-7-129 Tejasvi, 2012, TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis, J Invest Dermatol, 132, 593, 10.1038/jid.2011.376 Thome, 2008, Multifunctional roles for MALT1 in T-cell activation, Nat Rev Immunol, 8, 495, 10.1038/nri2338 Uren, 2000, Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma, Mol Cell, 6, 961 Wang, 2001, Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B, J Biol Chem, 276, 21405, 10.1074/jbc.M102488200 Wiesmann, 2012, Structural determinants of MALT1 protease activity, J Mol Biol, 419, 4, 10.1016/j.jmb.2012.02.018 Yim, 2016, Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms, Rheumatol Int Yu, 2015, MALT1 protease activity is required for innate and adaptive immune responses, PLoS One, 10, e0127083, 10.1371/journal.pone.0127083 Zhu, 2016, Variants of CARD14 gene and psoriasis vulgaris in southern Chinese cohort, An Bras Dermatol, 91, 45, 10.1590/abd1806-4841.20164016